March 18, 2024

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

PDF icon
EN PDF icon
NL
February 26, 2024

Invitation to a Special Shareholders’ Meeting

PDF icon
EN PDF icon
NL
February 22, 2024

Biotalys Reports Full-Year 2023 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
February 8, 2024

Biotalys Enters into Academic Collaborations with Key Scientific Leaders in Europe and U.S.

PDF icon
EN PDF icon
NL
January 31, 2024

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
January 22, 2024

Biotalys Notice of Full Year 2023 Results and Business Highlights

PDF icon
EN PDF icon
NL
December 19, 2023

Biotalys Announces Results of Independent Field Trials in the U.S.

PDF icon
EN PDF icon
NL
November 29, 2023

Biotalys Provides Company Update

PDF icon
EN PDF icon
NL
October 5, 2023

Kevin Helash commences role as Chief Executive Officer of Biotalys

PDF icon
EN PDF icon
NL
October 2, 2023

Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

PDF icon
EN PDF icon
NL
September 26, 2023

Biotalys announces participation at upcoming scientific, industry and investor events

PDF icon
EN PDF icon
NL
August 23, 2023

Biotalys Reports Half-Year 2023 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
July 20, 2023

Invitation to a Special Shareholders’ Meeting

PDF icon
EN PDF icon
NL
July 5, 2023

Publication of transparency notification

PDF icon
EN PDF icon
NL
June 12, 2023

Biotalys announces closing of private placement

PDF icon
EN PDF icon
NL